PlexBio Co., Ltd. (TPEX:6572)

Market Cap	658.17M -33.9%
Revenue (ttm)	137.57M -10.1%
Net Income	-38.38M
EPS	-0.37
Shares Out	103.65M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	215,970
Open	6.69
Previous Close	6.69
Day's Range	6.21 - 6.69
52-Week Range	5.16 - 15.80
Beta	1.09
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 13, 2026

About PlexBio

PlexBio Co., Ltd. develops and manufactures in vitro diagnostic reagents for molecular biology and immunology projects. It provides workflow navigation services; automated sample preparation kits; IntelliPlex platform that is designed for πCode technology with throughput sample-to-answer multiplexing assays; oncology assays, a portfolio for advanced molecular testing; and customized πCode assays. PlexBio Co., Ltd. was founded in 2009 and is based in Taipei, Taiwan.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2009
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 6572

Financial Performance

In 2025, PlexBio's revenue was 127.10 million, a decrease of -0.76% compared to the previous year's 128.06 million. Losses were -62.47 million, 1.36% more than in 2024.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 30, 2026

Data Sources Report a data error